|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quintanal-Villalonga Á and Molina-Pinelo
S: Epigenetics of lung cancer: A translational perspective. Cell
Oncol (Dordr). 42:739–756. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim D, Lee YS, Kim DH and Bae SC: Lung
cancer staging and associated genetic and epigenetic events. Mol
Cells. 43:1–9. 2020.PubMed/NCBI
|
|
4
|
Santamaria A, Neef R, Eberspächer U, Eis
K, Husemann M, Mumberg D, Prechtl S, Schulze V, Siemeister G,
Wortmann L, et al: Use of the novel Plk1 inhibitor
ZK-thiazolidinone to elucidate functions of Plk1 in early and late
stages of mitosis. Mol Biol Cell. 18:4024–4036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu Y, Chen X and Li Y: ERCC6L, a gene of
SNF2 family, may play a role in the teratogenic action of alcohol.
Toxicol Lett. 157:233–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin Y, Tang L, Zhang J, Tang B and Li Z:
Molecular Cloning and Gene Expression Analysis of ERCC6L in Sika
Deer (Cervus nippon hortulorum). PLoS One. 6:e209292011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baumann C, Körner R, Hofmann K and Nigg
EA: PICH, a centromere-associated SNF2 family ATPase, is regulated
by Plk1 and required for the spindle checkpoint. Cell. 128:101–114.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhola NE, Jansen VM, Bafna S, Giltnane JM,
Balko JM, Estrada MV, Meszoely I, Mayer I, Abramson V, Ye F, et al:
Correction: Kinome-wide functional screen identifies role of PLK1
in Hormone-independent, ER-positive breast cancer. Cancer Res.
79:8762019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Helmke C, Becker S and Strebhardt K: The
role of Plk3 in oncogenesis. Oncogene. 35:135–147. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abbasi R, Ramroth H, Becher H, Dietz A,
Schmezer P and Popanda O: Laryngeal cancer risk associated with
smoking and alcohol consumption is modified by genetic
polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms
in five other nucleotide excision repair genes. Int J Cancer.
125:1431–1439. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hübner NC, Wang LH, Kaulich M, Descombes
P, Poser I and Nigg EA: Re-examination of SiRNA specificity
questions role of PICH and Tao1 in the spindle checkpoint and
identifies Mad2 as A sensitive target for small RNAs. Chromosoma.
119:149–165. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang G, Ma J, Xiong J, Huang X, Han X, Yu
X and Jiang X: Upregulation of excision repair
cross-complementation group 6-Like (ERCC6L) promotes tumor growth
in hepatocellular carcinoma. Dig Dis Sci. 66:1097–1109. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rami-Porta R, Asamura H, Travis WD and
Rusch VW: Lung cancer-major changes in the American Joint Committee
on Cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:138–155. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamauchi M, Yamaguchi R, Nakata A, Kohno
T, Nagasaki M, Shimamura T, Imoto S, Saito A, Ueno K, Hatanaka Y,
et al: Epidermal growth factor receptor tyrosine kinase defines
critical prognostic genes of stage I lung adenocarcinoma. PLoS One.
7:e439232012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rousseaux S, Debernardi A, Jacquiau B,
Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY,
Lantuejoul S, Hainaut P, et al: Ectopic activation of germline and
placental genes identifies aggressive metastasis-prone lung
cancers. Sci Transl Med. 5:186ra662013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mermel CH, Schumacher SE, Hill B, Meyerson
ML, Beroukhim R and Getz G: GISTIC2. 0 facilitates sensitive and
confident localization of the targets of focal somatic copy-number
alteration in human cancers. Genome Biol. 12:R412011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nusinow DP, Szpyt J, Ghandi M, Rose CM,
McDonald ER III, Kalocsay M, Jané-Valbuena J, Gelfand E, Schweppe
DK, Jedrychowski M, et al: Quantitative proteomics of the cancer
cell line encyclopedia. Cell. 180:387–402.e16. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The cancer cell line encyclopedia enables
predictive modelling of anticancer drug sensitivity. Nature.
483:603–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46:D956–D963. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47:W556–W560. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yuan H, Yan M, Zhang G, Liu W, Deng C,
Liao G, Xu L, Luo T, Yan H, Long Z, et al: CancerSEA: A cancer
single-cell state atlas. Nucleic Acids Res. 47:D900–D908. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gong HX, He L, Li XP, Wang YD, Li Y, Huang
JJ, Wang Z, Xie D, Kung HF and Peng Y: Effective antitumor immunity
against murine gliomas using dendritic cells transduced with
hTERTC27 recombinant adenovirus. Oncol Rep. 27:1163–1169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Y, Guo Y, Tan S, Ke B, Tao J, Liu H,
Jiang J, Chen J, Chen G and Wu B: β-Arrestin1 enhances
hepatocellular carcinogenesis through inflammation-mediated Akt
signalling. Nat Commun. 6:73692015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin CH, Wang CH, Hsu SL, Liao LY, Lin TA
and Hsueh CM: Molecular mechanisms responsible for neuron-derived
conditioned medium (NCM)-mediated protection of ischemic brain.
PLoS One. 11:e01466922016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhong Y, Jiang L, Lin H, Li X, Long X,
Zhou Y, Li B and Li Z: Overexpression of KIF18A promotes cell
proliferation, inhibits apoptosis, and independently predicts
unfavorable prognosis in lung adenocarcinoma. IUBMB Life.
71:942–955. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhong Y, Jiang L, Long X, Zhou Y, Deng S,
Lin H and Li X: Clinical significance and integrative analysis of
kinesin family member 18B in lung adenocarcinoma. OncoTargets Ther.
12:9249–9264. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao Z, Zhang G and Li W: Elevated
Expression of ERCC6 confers resistance to 5-fluorouracil and is
associated with poor patient survival in colorectal cancer. DNA
Cell Biol. 36:781–786. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo SS, Liao XW, Zhu XD and Doetsch PW:
Prognostic value of excision repair cross-complementing mRNA
expression in gastric cancer. Biomed Res Int. 2018:62046842018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pu SY, Yu Q, Wu H, Jiang JJ, Chen XQ, He
YH and Kong QP: ERCC6L, A DNA helicase, is involved in cell
proliferation and associated with survival and progress in breast
and kidney cancers. Oncotarget. 8:42116–42124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu B, Liang H, Ye Q and Wang Y:
Upregulation of ERCC6L is associated with tumor progression and
unfavorable prognosis in hepatocellular carcinoma. J Gastrointest
Oncol. 11:1009–1023. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang Y, Li W, Yan W, Wu J, Chen L, Yao X,
Gu F, Lv L, Zhao J, Zhao M, et al: Loss of PICH promotes chromosome
instability and cell death in triple-negative breast cancer. Cell
Death Dis. 10:4282019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gamazon ER and Stranger BE: The impact of
human copy number variation on gene expression. Brief Funct
Genomics. 14:352–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao Y and Teschendorff AE: Epigenetic and
genetic deregulation in cancer target distinct signaling pathway
domains. Nucleic Acids Res. 45:583–596. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ingham M and Schwartz GK: Cell-cycle
therapeutics come of age. J Clin Oncol. 35:2949–2959. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang G, Yu Z, Fu S, Lv C, Dong Q, Fu C,
Kong C and Zeng Y: ERCC6L That Is Up-regulated in high grade of
renal cell carcinoma enhances cell viability in vitro and promotes
tumor growth in vivo potentially through modulating MAPK signalling
pathway. Cancer Gene Ther. 26:323–333. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen H, Wang H, Yu X, Zhou S, Zhang Y and
Wang Z, Huang S and Wang Z: ERCC6L Promotes the progression of
hepatocellular carcinoma through activating PI3K/AKT and NF-κB
signaling pathway. BMC Cancer. 20:8532020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fernandez-Cuesta L, Peifer M, Lu X, Sun R,
Ozretić L, Seidal D, Zander T, Leenders F, George J, Müller C, et
al: Frequent mutations in chromatin-remodelling genes in pulmonary
carcinoids. Nature Commun. 5:35182014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kurasawa Y and Yu-Lee LY: PICH and
cotargeted Plk1 coordinately maintain prometaphase chromosome arm
architecture. Mol Biol Cell. 21:1188–1199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rouzeau S, Cordelières FP,
Buhagiar-Labarchède G, Hurbain I, Onclercq-Delic R, Gemble S,
Magnaghi-Jaulin L, Jaulin C and Amor-Guéret M: Bloom's Syndrome and
PICH Helicases cooperate with topoisomerase IIα in centromere
disjunction before anaphase. PLoS One. 7:e339052012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Leng M, Besusso D, Jung SY, Wang Y and Qin
J: Targeting Plk1 to chromosome arms and regulating chromosome
compaction by the PICH ATPase. Cell Cycle. 7:1480–1489. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Albers E, Sbroggiò M, Pladevall-Morera D,
Bizard AH, Avram A, Gonzalez P, Martin-Gonzalez J, Hickson ID and
Lopez-Contreras AJ: Loss of PICH results in chromosomal
instability, p53 activation, and embryonic lethality. Cell Rep.
24:3274–3284. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu J, Sun J, Zhang Q and Zeng Z: shRNA
knockdown of DNA Helicase ERCC6L expression inhibits human breast
cancer growth. Mol Med Rep. 18:3490–3496. 2018.PubMed/NCBI
|
|
49
|
Greenburg G and Hay ED: Epithelia
suspended in collagen gels can lose polarity and express
characteristics of migrating mesenchymal cells. J Cell Biol.
95:333–339. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nawshad A, LaGamba D, Polad A and Hay ED:
Transforming growth factor-beta signaling during
epithelial-mesenchymal transformation: Implications for
embryogenesis and tumor metastasis. Cells Tissues Organs.
179:11–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Otsuki Y, Saya H and Arima Y: Prospects
for new lung cancer treatments that target EMT signaling. Dev Dyn.
247:462–472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Vu T and Datta PK: Regulation of EMT in
colorectal cancer: A culprit in metastasis. Cancers (Basel).
9:1712017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kaszak I, Witkowska-Piłaszewicz O,
Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F and Jurka P: Role
of cadherins in cancer-a review. Int J Mol Sci. 21:76242020.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shook D and Keller R: Mechanisms,
mechanics and function of epithelial-mesenchymal transitions in
early development. Mech Dev. 120:1351–1383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wong SHM, Fang CM, Chuah LH, Leong CO and
Ngai SC: E-cadherin: Its dysregulation in carcinogenesis and
clinical implications. Crit Rev Oncol Hematol. 121:11–22. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tafrihi M and Nakhaei Sistani R:
E-Cadherin/β-catenin complex: A target for anticancer and
antimetastasis plants/plant-derived compounds. Nutr Cancer.
69:702–722. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Al-Alem L and Curry TE Jr: Ovarian cancer:
Involvement of the matrix metalloproteinases. Reproduction.
150:R55–R64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kenny HA and Lengyel E: MMP-2 functions as
an early response protein in ovarian cancer metastasis. Cell Cycle.
8:683–688. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mendonsa AM, Na TY and Gumbiner BM:
E-cadherin in contact inhibition and cancer. Oncogene.
37:4769–4780. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Nguyen VHL, Hough R, Bernaudo S and Peng
C: Wnt/β-catenin signalling in ovarian cancer: Insights into its
hyperactivation and function in tumorigenesis. J Ovarian Res.
12:1222019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Siebel C and Lendahl U: Notch signaling in
development, tissue homeostasis, and disease. Physiol Rev.
97:1235–1294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
O'Leary K, Shia A and Schmid P: Epigenetic
regulation of EMT in non-small cell lung cancer. Curr Cancer Drug
Targets. 18:89–96. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Xie Y, Yu J, Wang F, Li M, Qiu X, Liu Y
and Qi J: ERCC6L Promotes Cell Growth and Invasion in Human
Colorectal Cancer. Oncol Lett. 18:237–246. 2019.PubMed/NCBI
|
